Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Supplement—May 2025
SUPPLEMENT ISSUE
Supplement
SARS-CoV-2 Genomic Surveillance from Community-Distributed Rapid Antigen Tests, Wisconsin, USA
Table 1
Monthly distribution and return of research packages in a study of SARS-CoV-2 genomic surveillance from community-distributed rapid antigen tests, Wisconsin, USA*
Collection month | Approximate no. packets supplied for RAT collection | No. packets with positive tests | No. tests that passed sequencing quality threshold† |
---|---|---|---|
2023 | |||
Aug | 100 | 13 | 5 |
Sep | 1,470 | 33 | 14 |
Oct | 1,390 | 37 | 18 |
Nov | 2,405 | 33 | 21 |
Dec |
300 |
46 |
28 |
2024 | |||
Jan | 1,160 | 28 | 20 |
Feb |
950 |
33 |
21 |
Total no. | 7,775 | 223 | 127 |
*RATs, rapid antigen tests. †Quality threshold was >10× depth of coverage for >90% of the SARS-CoV-2 genome.
Page created: February 05, 2025
Page updated: May 02, 2025
Page reviewed: May 02, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.